CYLD in ubiquitin signaling and tumor pathogenesis

被引:23
作者
Ikeda, Fumiyo [1 ]
Dikic, Ivan [1 ]
机构
[1] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany
关键词
D O I
10.1016/j.cell.2006.05.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Absence of CYLD, which encodes a deubiquitinating enzyme, causes an inherited disease characterized by benign skin tumors. In this issue of Cell, Massoumi et al. (2006) show that CYLD deubiquitinates the coactivator Bcl-3, thereby preventing its translocation into the nucleus, where it normally interacts with NF-kappa B and activates transcription of proliferation genes in response to growth signals.
引用
收藏
页码:643 / 645
页数:3
相关论文
共 9 条
[1]   Identification of the familial cylindromatosis tumour-suppressor gene [J].
Bignell, GR ;
Warren, W ;
Seal, S ;
Takahashi, M ;
Rapley, E ;
Barfoot, R ;
Green, H ;
Brown, C ;
Biggs, PJ ;
Lakhani, SR ;
Jones, C ;
Hansen, J ;
Blair, E ;
Hofmann, B ;
Siebert, R ;
Turner, G ;
Evans, DG ;
Schrander-Stumpel, C ;
Beemer, FA ;
van den Ouweland, A ;
Halley, D ;
Delpech, B ;
Cleveland, MG ;
Leigh, I ;
Leisti, J ;
Rasmussen, S ;
Wallace, MR ;
Fenske, C ;
Banerjee, P ;
Oiso, N ;
Chaggar, R ;
Merrett, S ;
Leonard, N ;
Huber, M ;
Hohl, D ;
Chapman, P ;
Burn, J ;
Swift, S ;
Smith, A ;
Ashworth, A ;
Stratton, MR .
NATURE GENETICS, 2000, 25 (02) :160-165
[2]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[3]   Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions [J].
Franzoso, G ;
Carlson, L ;
SchartonKersten, T ;
Shores, EW ;
Epstein, S ;
Grinberg, A ;
Tran, T ;
Shacter, E ;
Leonardi, A ;
Anver, M ;
Love, P ;
Sher, A ;
Siebenlist, U .
IMMUNITY, 1997, 6 (04) :479-490
[4]   Ubiquitylation and cell signaling [J].
Haglund, K ;
Dikic, I .
EMBO JOURNAL, 2005, 24 (19) :3353-3359
[5]   Signaling to NF-κB [J].
Hayden, MS ;
Ghosh, S .
GENES & DEVELOPMENT, 2004, 18 (18) :2195-2224
[6]   The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination [J].
Kovalenko, A ;
Chable-Bessia, C ;
Cantarella, G ;
Israël, A ;
Wallach, D ;
Courtois, G .
NATURE, 2003, 424 (6950) :801-805
[7]   Regulation of T cell development by the deubiquitinating enzyme CYLD [J].
Reiley, WW ;
Zhang, MY ;
Jin, W ;
Losiewicz, M ;
Donohue, KB ;
Norbury, CC ;
Sun, SC .
NATURE IMMUNOLOGY, 2006, 7 (04) :411-417
[8]   CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members [J].
Trompouki, E ;
Hatzivassiliou, E ;
Tsichritzis, T ;
Farmer, H ;
Ashworth, A ;
Mosialos, G .
NATURE, 2003, 424 (6950) :793-796
[9]   Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: Generation of NF-kappa B homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation [J].
Watanabe, N ;
Iwamura, T ;
Shinoda, T ;
Fujita, T .
EMBO JOURNAL, 1997, 16 (12) :3609-3620